Clinical Trial Update: Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the safety and efficacy of Alfimeprase in patients with occluded central venous catheters due to thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis
• Venous Thrombosis

Drugs mentioned

• Alfimeprase (alfimeprase)

Snippet

Sponsor: ARCA Biopharma, Inc. | Conditions: Thrombosis, Venous Thrombosis | Phase 3 | Status: COMPLETED